Treatment Outcomes of Non- Adenocarcinoma Prostate in a Developing Country

Abstract

Objective: To assess the oncological outcomes of non-adenocarcinoma prostate cancers in a specialized cancer hospital in a developing country.

Study Design: Retrospective study.

Place and Duration of Study: This study was conducted at the Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore from January 2002 to July 2017.

Materials and Methods: All the patients with prostate cancer were studied retrospectively. The patients with ages more than 18 years and having histologically proven non-adenocarcinoma prostate cancers were selected for this study.

Results: A total of 7 patients of non-adeno prostate cancer were identified. The most common presenting complaint was acute urinary retention (57.1%) followed by hematuria (14.3%). As per TNM staging, most of the patients belonged to T4 (57.1%), N1 (57.1%) and M1 (57.1%). Radical chemotherapy and radiotherapy were given to 4 (71.4%) patients. Local recurrence was found in 1 (14.3%) and metastasis were reported in 4 of the patients andthe mortality rate was 71.4%.

Conclusion: Chemotherapy, radiotherapy and surgery were the main treatment modalities. Low recurrence and high mortality rates were observed.